0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Immuno Oncology Assays - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: October 2024
|
Report Code: QYRE-Auto-29T5897
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Immuno Oncology Assays Market Insights and Forecast to 2028
BUY CHAPTERS

Immuno Oncology Assays - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-29T5897
Report
October 2024
Pages:78
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Immuno Oncology Assays - Market Size

The global market for Immuno Oncology Assays was estimated to be worth US$ 4439.4 million in 2023 and is forecast to a readjusted size of US$ 9297.8 million by 2030 with a CAGR of 10.9% during the forecast period 2024-2030

Immuno Oncology Assays - Market

Immuno Oncology Assays - Market

Immuno-Oncology Assays Accelerate Cancer Immunotherapy enable fast, effective, and clinically relevant understanding of immuno-oncology targets, pathways and mechanisms, enabling quicker development of immuno-oncology drugs. Learn how you can rapidly screen and develop antibodies targeting checkpoint receptors, bi-specific antibodies, small molecules, or cellular therapies such as chimeric antigen receptor T-cells (CAR-T).
North American market for Immuno Oncology Assays was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Immuno Oncology Assays was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Immuno Oncology Assays was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Immuno Oncology Assays include Thermo Fischer Scientific, Roche Diagnostics, Agilent Technologies and Illumina, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Immuno Oncology Assays, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Immuno Oncology Assays by region & country, by Type, and by Application.
The Immuno Oncology Assays market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Immuno Oncology Assays.
Market Segmentation

Scope of Immuno Oncology Assays - Market Report

Report Metric Details
Report Name Immuno Oncology Assays - Market
Forecasted market size in 2030 US$ 9297.8 million
CAGR 10.9%
Forecasted years 2024 - 2030
Segment by Type:
  • Immunoassay
  • Flow Cytometry
  • PCR
  • Next Generation Sequencing
Segment by Application
  • Research
  • Clinical Diagnostics
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Thermo Fischer Scientific, Roche Diagnostics, Agilent Technologies, Illumina
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Immuno Oncology Assays manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Revenue of Immuno Oncology Assays in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Revenue of Immuno Oncology Assays in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Immuno Oncology Assays - Market size in 2030?

Ans: The Immuno Oncology Assays - Market size in 2030 will be US$ 9297.8 million.

Who are the main players in the Immuno Oncology Assays - Market report?

Ans: The main players in the Immuno Oncology Assays - Market are Thermo Fischer Scientific, Roche Diagnostics, Agilent Technologies, Illumina

What are the Application segmentation covered in the Immuno Oncology Assays - Market report?

Ans: The Applications covered in the Immuno Oncology Assays - Market report are Research, Clinical Diagnostics

What are the Type segmentation covered in the Immuno Oncology Assays - Market report?

Ans: The Types covered in the Immuno Oncology Assays - Market report are Immunoassay, Flow Cytometry, PCR, Next Generation Sequencing

1 Market Overview
1.1 Immuno Oncology Assays Product Introduction
1.2 Global Immuno Oncology Assays Market Size Forecast
1.3 Immuno Oncology Assays Market Trends & Drivers
1.3.1 Immuno Oncology Assays Industry Trends
1.3.2 Immuno Oncology Assays Market Drivers & Opportunity
1.3.3 Immuno Oncology Assays Market Challenges
1.3.4 Immuno Oncology Assays Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Immuno Oncology Assays Players Revenue Ranking (2023)
2.2 Global Immuno Oncology Assays Revenue by Company (2019-2024)
2.3 Key Companies Immuno Oncology Assays Manufacturing Base Distribution and Headquarters
2.4 Key Companies Immuno Oncology Assays Product Offered
2.5 Key Companies Time to Begin Mass Production of Immuno Oncology Assays
2.6 Immuno Oncology Assays Market Competitive Analysis
2.6.1 Immuno Oncology Assays Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Immuno Oncology Assays Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immuno Oncology Assays as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Immunoassay
3.1.2 Flow Cytometry
3.1.3 PCR
3.1.4 Next Generation Sequencing
3.2 Global Immuno Oncology Assays Sales Value by Type
3.2.1 Global Immuno Oncology Assays Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Immuno Oncology Assays Sales Value, by Type (2019-2030)
3.2.3 Global Immuno Oncology Assays Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Research
4.1.2 Clinical Diagnostics
4.2 Global Immuno Oncology Assays Sales Value by Application
4.2.1 Global Immuno Oncology Assays Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Immuno Oncology Assays Sales Value, by Application (2019-2030)
4.2.3 Global Immuno Oncology Assays Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Immuno Oncology Assays Sales Value by Region
5.1.1 Global Immuno Oncology Assays Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Immuno Oncology Assays Sales Value by Region (2019-2024)
5.1.3 Global Immuno Oncology Assays Sales Value by Region (2025-2030)
5.1.4 Global Immuno Oncology Assays Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Immuno Oncology Assays Sales Value, 2019-2030
5.2.2 North America Immuno Oncology Assays Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Immuno Oncology Assays Sales Value, 2019-2030
5.3.2 Europe Immuno Oncology Assays Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Immuno Oncology Assays Sales Value, 2019-2030
5.4.2 Asia Pacific Immuno Oncology Assays Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Immuno Oncology Assays Sales Value, 2019-2030
5.5.2 South America Immuno Oncology Assays Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Immuno Oncology Assays Sales Value, 2019-2030
5.6.2 Middle East & Africa Immuno Oncology Assays Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Immuno Oncology Assays Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Immuno Oncology Assays Sales Value
6.3 United States
6.3.1 United States Immuno Oncology Assays Sales Value, 2019-2030
6.3.2 United States Immuno Oncology Assays Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Immuno Oncology Assays Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Immuno Oncology Assays Sales Value, 2019-2030
6.4.2 Europe Immuno Oncology Assays Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Immuno Oncology Assays Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Immuno Oncology Assays Sales Value, 2019-2030
6.5.2 China Immuno Oncology Assays Sales Value by Type (%), 2023 VS 2030
6.5.3 China Immuno Oncology Assays Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Immuno Oncology Assays Sales Value, 2019-2030
6.6.2 Japan Immuno Oncology Assays Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Immuno Oncology Assays Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Immuno Oncology Assays Sales Value, 2019-2030
6.7.2 South Korea Immuno Oncology Assays Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Immuno Oncology Assays Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Immuno Oncology Assays Sales Value, 2019-2030
6.8.2 Southeast Asia Immuno Oncology Assays Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Immuno Oncology Assays Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Immuno Oncology Assays Sales Value, 2019-2030
6.9.2 India Immuno Oncology Assays Sales Value by Type (%), 2023 VS 2030
6.9.3 India Immuno Oncology Assays Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Thermo Fischer Scientific
7.1.1 Thermo Fischer Scientific Profile
7.1.2 Thermo Fischer Scientific Main Business
7.1.3 Thermo Fischer Scientific Immuno Oncology Assays Products, Services and Solutions
7.1.4 Thermo Fischer Scientific Immuno Oncology Assays Revenue (US$ Million) & (2019-2024)
7.1.5 Thermo Fischer Scientific Recent Developments
7.2 Roche Diagnostics
7.2.1 Roche Diagnostics Profile
7.2.2 Roche Diagnostics Main Business
7.2.3 Roche Diagnostics Immuno Oncology Assays Products, Services and Solutions
7.2.4 Roche Diagnostics Immuno Oncology Assays Revenue (US$ Million) & (2019-2024)
7.2.5 Roche Diagnostics Recent Developments
7.3 Agilent Technologies
7.3.1 Agilent Technologies Profile
7.3.2 Agilent Technologies Main Business
7.3.3 Agilent Technologies Immuno Oncology Assays Products, Services and Solutions
7.3.4 Agilent Technologies Immuno Oncology Assays Revenue (US$ Million) & (2019-2024)
7.3.5 Illumina Recent Developments
7.4 Illumina
7.4.1 Illumina Profile
7.4.2 Illumina Main Business
7.4.3 Illumina Immuno Oncology Assays Products, Services and Solutions
7.4.4 Illumina Immuno Oncology Assays Revenue (US$ Million) & (2019-2024)
7.4.5 Illumina Recent Developments
8 Industry Chain Analysis
8.1 Immuno Oncology Assays Industrial Chain
8.2 Immuno Oncology Assays Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Immuno Oncology Assays Sales Model
8.5.2 Sales Channel
8.5.3 Immuno Oncology Assays Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Immuno Oncology Assays Market Trends
    Table 2. Immuno Oncology Assays Market Drivers & Opportunity
    Table 3. Immuno Oncology Assays Market Challenges
    Table 4. Immuno Oncology Assays Market Restraints
    Table 5. Global Immuno Oncology Assays Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Immuno Oncology Assays Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies Immuno Oncology Assays Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies Immuno Oncology Assays Product Type
    Table 9. Key Companies Time to Begin Mass Production of Immuno Oncology Assays
    Table 10. Global Immuno Oncology Assays Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immuno Oncology Assays as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global Immuno Oncology Assays Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global Immuno Oncology Assays Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global Immuno Oncology Assays Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global Immuno Oncology Assays Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global Immuno Oncology Assays Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global Immuno Oncology Assays Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global Immuno Oncology Assays Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global Immuno Oncology Assays Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global Immuno Oncology Assays Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global Immuno Oncology Assays Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global Immuno Oncology Assays Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global Immuno Oncology Assays Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global Immuno Oncology Assays Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global Immuno Oncology Assays Sales Value by Region (2019-2024) & (%)
    Table 27. Global Immuno Oncology Assays Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions Immuno Oncology Assays Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions Immuno Oncology Assays Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions Immuno Oncology Assays Sales Value, (2025-2030) & (US$ Million)
    Table 31. Thermo Fischer Scientific Basic Information List
    Table 32. Thermo Fischer Scientific Description and Business Overview
    Table 33. Thermo Fischer Scientific Immuno Oncology Assays Products, Services and Solutions
    Table 34. Revenue (US$ Million) in Immuno Oncology Assays Business of Thermo Fischer Scientific (2019-2024)
    Table 35. Thermo Fischer Scientific Recent Developments
    Table 36. Roche Diagnostics Basic Information List
    Table 37. Roche Diagnostics Description and Business Overview
    Table 38. Roche Diagnostics Immuno Oncology Assays Products, Services and Solutions
    Table 39. Revenue (US$ Million) in Immuno Oncology Assays Business of Roche Diagnostics (2019-2024)
    Table 40. Roche Diagnostics Recent Developments
    Table 41. Agilent Technologies Basic Information List
    Table 42. Agilent Technologies Description and Business Overview
    Table 43. Agilent Technologies Immuno Oncology Assays Products, Services and Solutions
    Table 44. Revenue (US$ Million) in Immuno Oncology Assays Business of Agilent Technologies (2019-2024)
    Table 45. Agilent Technologies Recent Developments
    Table 46. Illumina Basic Information List
    Table 47. Illumina Description and Business Overview
    Table 48. Illumina Immuno Oncology Assays Products, Services and Solutions
    Table 49. Revenue (US$ Million) in Immuno Oncology Assays Business of Illumina (2019-2024)
    Table 50. Illumina Recent Developments
    Table 51. Key Raw Materials Lists
    Table 52. Raw Materials Key Suppliers Lists
    Table 53. Immuno Oncology Assays Downstream Customers
    Table 54. Immuno Oncology Assays Distributors List
    Table 55. Research Programs/Design for This Report
    Table 56. Key Data Information from Secondary Sources
    Table 57. Key Data Information from Primary Sources
    Table 58. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. Immuno Oncology Assays Product Picture
    Figure 2. Global Immuno Oncology Assays Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Immuno Oncology Assays Sales Value (2019-2030) & (US$ Million)
    Figure 4. Immuno Oncology Assays Report Years Considered
    Figure 5. Global Immuno Oncology Assays Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Immuno Oncology Assays Revenue in 2023
    Figure 7. Immuno Oncology Assays Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. Immunoassay Picture
    Figure 9. Flow Cytometry Picture
    Figure 10. PCR Picture
    Figure 11. Next Generation Sequencing Picture
    Figure 12. Global Immuno Oncology Assays Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 13. Global Immuno Oncology Assays Sales Value Market Share by Type, 2023 & 2030
    Figure 14. Product Picture of Research
    Figure 15. Product Picture of Clinical Diagnostics
    Figure 16. Global Immuno Oncology Assays Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 17. Global Immuno Oncology Assays Sales Value Market Share by Application, 2023 & 2030
    Figure 18. North America Immuno Oncology Assays Sales Value (2019-2030) & (US$ Million)
    Figure 19. North America Immuno Oncology Assays Sales Value by Country (%), 2023 VS 2030
    Figure 20. Europe Immuno Oncology Assays Sales Value (2019-2030) & (US$ Million)
    Figure 21. Europe Immuno Oncology Assays Sales Value by Country (%), 2023 VS 2030
    Figure 22. Asia Pacific Immuno Oncology Assays Sales Value (2019-2030) & (US$ Million)
    Figure 23. Asia Pacific Immuno Oncology Assays Sales Value by Country (%), 2023 VS 2030
    Figure 24. South America Immuno Oncology Assays Sales Value (2019-2030) & (US$ Million)
    Figure 25. South America Immuno Oncology Assays Sales Value by Country (%), 2023 VS 2030
    Figure 26. Middle East & Africa Immuno Oncology Assays Sales Value (2019-2030) & (US$ Million)
    Figure 27. Middle East & Africa Immuno Oncology Assays Sales Value by Country (%), 2023 VS 2030
    Figure 28. Key Countries/Regions Immuno Oncology Assays Sales Value (%), (2019-2030)
    Figure 29. United States Immuno Oncology Assays Sales Value, (2019-2030) & (US$ Million)
    Figure 30. United States Immuno Oncology Assays Sales Value by Type (%), 2023 VS 2030
    Figure 31. United States Immuno Oncology Assays Sales Value by Application (%), 2023 VS 2030
    Figure 32. Europe Immuno Oncology Assays Sales Value, (2019-2030) & (US$ Million)
    Figure 33. Europe Immuno Oncology Assays Sales Value by Type (%), 2023 VS 2030
    Figure 34. Europe Immuno Oncology Assays Sales Value by Application (%), 2023 VS 2030
    Figure 35. China Immuno Oncology Assays Sales Value, (2019-2030) & (US$ Million)
    Figure 36. China Immuno Oncology Assays Sales Value by Type (%), 2023 VS 2030
    Figure 37. China Immuno Oncology Assays Sales Value by Application (%), 2023 VS 2030
    Figure 38. Japan Immuno Oncology Assays Sales Value, (2019-2030) & (US$ Million)
    Figure 39. Japan Immuno Oncology Assays Sales Value by Type (%), 2023 VS 2030
    Figure 40. Japan Immuno Oncology Assays Sales Value by Application (%), 2023 VS 2030
    Figure 41. South Korea Immuno Oncology Assays Sales Value, (2019-2030) & (US$ Million)
    Figure 42. South Korea Immuno Oncology Assays Sales Value by Type (%), 2023 VS 2030
    Figure 43. South Korea Immuno Oncology Assays Sales Value by Application (%), 2023 VS 2030
    Figure 44. Southeast Asia Immuno Oncology Assays Sales Value, (2019-2030) & (US$ Million)
    Figure 45. Southeast Asia Immuno Oncology Assays Sales Value by Type (%), 2023 VS 2030
    Figure 46. Southeast Asia Immuno Oncology Assays Sales Value by Application (%), 2023 VS 2030
    Figure 47. India Immuno Oncology Assays Sales Value, (2019-2030) & (US$ Million)
    Figure 48. India Immuno Oncology Assays Sales Value by Type (%), 2023 VS 2030
    Figure 49. India Immuno Oncology Assays Sales Value by Application (%), 2023 VS 2030
    Figure 50. Immuno Oncology Assays Industrial Chain
    Figure 51. Immuno Oncology Assays Manufacturing Cost Structure
    Figure 52. Channels of Distribution (Direct Sales, and Distribution)
    Figure 53. Bottom-up and Top-down Approaches for This Report
    Figure 54. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS